Skip to main content
. 2022 Jul 18;13:928062. doi: 10.3389/fimmu.2022.928062

Figure 3.

Figure 3

Underlying primary immunodeficiency (PID) in autoimmune cytopenia: early diagnosis can alter the treatment pathway. AIHA, autoimmune hemolytic anemia; ALPS, autoimmune lymphoproliferative syndrome; CVID, common variable immune deficiency; HD, high dose; Hgb, hemoglobin; IEI, inborn error of metabolism (=primary immunodeficiency); ITP, immune thrombocytopenia; IVIg, intravenous immunoglobulin; RTX, rituximab.